March 23, 2017
Futura medical decreases loss in 2016
Futura medical, healthcare company focused on advanced transdermal technology, has announced its preliminary results for the year 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 23, 2017
£200 million to U.K. Biobank for genetics-guided drug development
A major research has been initiated, which will enable researchers to gain valuable insights to support advances in the development of new medicines for a wide range of serious and life threatening diseases.
March 23, 2017
Alcon wins FDA’s approval for its intraocular lens for cataract surgery patients
Alcon, a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens (IOL) with Activefocus optical design for patients undergoing cataract surgery who choose to address their astigmatism and presbyopia at the same time.
March 22, 2017
Verona Pharma and QuintilesIMS in strategic agreement to develop respiratory drugs
Verona Pharma, a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases, has entered into a global strategic services agreement with QuintilesIMS, a provider of biopharmaceutical development and commercial outsourcing services.
March 22, 2017
FDA OK’s Parkinson’s disease drug
The U.S. Food and Drug Administration has approved Newron Pharmaceuticals’s Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa.
March 22, 2017
Galapagos nets $7.5 million from partner for reaching milestone in a study
Galapagos NV has reached a milestone in a Phase 1 study for cystic fibrosis, it is conducting with its partner AbbVie, …
March 22, 2017
Novartis’s acute heart failure drug disappoints at phase III study
Novartis’s acute heart failure (AHF) drug study did not meet its primary endpoint of reduction in cardiovascular death through Day 180 or reduced worsening heart failure through Day five when added to standard therapy
March 22, 2017
Venn Life Sciences’s profit up
Venn Life Sciences, a Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has reported profit of €0,5 million for the 2016.
March 21, 2017
Steep Hill Labs and iCAN:Israel-Cannabis join in cannabis business
Steep Hill Labs, a cannabis science and technology company has entered a joint venture with iCAN:Israel-Cannabis to leverage Steep Hill’s science, IP, methodology, global collaboration and brand.
March 21, 2017
Researchers find that crucial cancer-related protein can help suppress the brain tumor
St. Jude Children’s Research Hospital scientists in association with other researchers have worked out how a crucial cancer-related protein, a “histone writer” called Ezh2, plays a role in suppressing as well as driving the most aggressive form of the brain tumor medulloblastoma.